Chris A. Lemmon, MD

Lemmon, Christopher A; Zhou, Jie; Hobbs, Brian; Pennell, Nathan A 2023. Modeling Costs and Life-Years Gained by Population-Wide Next-Generation Sequencing or Single-Gene Testing in Nonsquamous Non-Small-Cell Lung Cancer in the United States. JCO precision oncology, 7 , e2200294

Lemmon, Christopher A; Videtic, Gregory M M; Murthy, Sudish; Stephans, Kevin L; Shapiro, Marc; Ahmad, Usman; Raymond, Daniel; Velcheti, Vamsidhar; Bribriesco, Alejandro; Jia, Xuefei; Stevenson, James; Pennell, Nathan A 2022. A Phase 1 Study of Concurrent Neoadjuvant Pembrolizumab Plus Chemoradiation Followed by Consolidation Pembrolizumab in Patients With Resectable Stage IIIA NSCLC. JTO clinical and research reports, 3 7, 100359

Lemmon, Christopher A; Zabor, Emily C; Pennell, Nathan A 2022. Modeling the Cost-Effectiveness of Adjuvant Osimertinib for Patients with Resected EGFR-mutant Non-Small Cell Lung Cancer. The oncologist, 27 5, 407-413

, 2020. A Systematic Framework to Rapidly Obtain Data on Patients with Cancer and COVID-19: CCC19 Governance, Protocol, and Quality Assurance. Cancer cell, 38 6, 761-766

Kuderer, Nicole M; Choueiri, Toni K; Shah, Dimpy P; Shyr, Yu; Rubinstein, Samuel M; Rivera, Donna R; Shete, Sanjay; Hsu, Chih-Yuan; Desai, Aakash; de Lima Lopes, Gilberto; Grivas, Petros; Painter, Corrie A; Peters, Solange; Thompson, Michael A; Bakouny, Ziad; Batist, Gerald; Bekaii-Saab, Tanios; Bilen, Mehmet A; Bouganim, Nathaniel; Larroya, Mateo Bover; Castellano, Daniel; Del Prete, Salvatore A; Doroshow, Deborah B; Egan, Pamela C; Elkrief, Arielle; Farmakiotis, Dimitrios; Flora, Daniel; Galsky, Matthew D; Glover, Michael J; Griffiths, Elizabeth A; Gulati, Anthony P; Gupta, Shilpa; Hafez, Navid; Halfdanarson, Thorvardur R; Hawley, Jessica E; Hsu, Emily; Kasi, Anup; Khaki, Ali R; Lemmon, Christopher A; Lewis, Colleen; Logan, Barbara; Masters, Tyler; McKay, Rana R; Mesa, Ruben A; Morgans, Alicia K; Mulcahy, Mary F; Panagiotou, Orestis A; Peddi, Prakash; Pennell, Nathan A; Reynolds, Kerry; Rosen, Lane R; Rosovsky, Rachel; Salazar, Mary; Schmidt, Andrew; Shah, Sumit A; Shaya, Justin A; Steinharter, John; Stockerl-Goldstein, Keith E; Subbiah, Suki; Vinh, Donald C; Wehbe, Firas H; Weissmann, Lisa B; Wu, Julie Tsu-Yu; Wulff-Burchfield, Elizabeth; Xie, Zhuoer; Yeh, Albert; Yu, Peter P; Zhou, Alice Y; Zubiri, Leyre; Mishra, Sanjay; Lyman, Gary H; Rini, Brian I; Warner, Jeremy L 2020. Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study. Lancet (London, England), 395 10241, 1907-1918

Lemmon, Christopher; Pennell, Nathan A 2020. Use of adjuvant EGFR tyrosine kinase inhibitors in early stage EGFR-mutant non-small cell lung cancer: is the evidence strong enough? Journal of thoracic disease, 12 9, 5042-5045

Rivera, Donna R; Peters, Solange; Panagiotou, Orestis A; Shah, Dimpy P; Kuderer, Nicole M; Hsu, Chih-Yuan; Rubinstein, Samuel M; Lee, Brendan J; Choueiri, Toni K; de Lima Lopes, Gilberto; Grivas, Petros; Painter, Corrie A; Rini, Brian I; Thompson, Michael A; Arcobello, Jonathan; Bakouny, Ziad; Doroshow, Deborah B; Egan, Pamela C; Farmakiotis, Dimitrios; Fecher, Leslie A; Friese, Christopher R; Galsky, Matthew D; Goel, Sanjay; Gupta, Shilpa; Halfdanarson, Thorvardur R; Halmos, Balazs; Hawley, Jessica E; Khaki, Ali Raza; Lemmon, Christopher A; Mishra, Sanjay; Olszewski, Adam J; Pennell, Nathan A; Puc, Matthew M; Revankar, Sanjay G; Schapira, Lidia; Schmidt, Andrew; Schwartz, Gary K; Shah, Sumit A; Wu, Julie T; Xie, Zhuoer; Yeh, Albert C; Zhu, Huili; Shyr, Yu; Lyman, Gary H; Warner, Jeremy L 2020. Utilization of COVID-19 Treatments and Clinical Outcomes among Patients with Cancer: A COVID-19 and Cancer Consortium (CCC19) Cohort Study. Cancer discovery, 10 10, 1514-1527